198 related articles for article (PubMed ID: 34408811)
1. CKS1B promotes the progression of hepatocellular carcinoma by activating JAK/STAT3 signal pathway.
Liu X; Zhao D
Anim Cells Syst (Seoul); 2021; 25(4):227-234. PubMed ID: 34408811
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.
Huang S; Zhou D; Li YX; Ming ZY; Li KZ; Wu GB; Chen C; Zhao YN
J Cell Physiol; 2019 Apr; 234(4):3500-3514. PubMed ID: 30370582
[TBL] [Abstract][Full Text] [Related]
3. CKS1B promotes cell proliferation and invasion by activating STAT3/PD-L1 and phosphorylation of Akt signaling in papillary thyroid carcinoma.
Wang H; Zhang Z; Yan Z; Ma S
J Clin Lab Anal; 2021 Jan; 35(1):e23565. PubMed ID: 32960462
[TBL] [Abstract][Full Text] [Related]
4. HIF‑1α and RACGAP1 promote the progression of hepatocellular carcinoma in a mutually regulatory way.
Wu X; Xu Z; Li W; Lu Y; Pu J
Mol Med Rep; 2023 Nov; 28(5):. PubMed ID: 37772389
[TBL] [Abstract][Full Text] [Related]
5. LINC00346 promotes hepatocellular carcinoma progression via activating the JAK-STAT3 signaling pathway.
Yin YZ; Zheng WH; Zhang X; Chen YH; Tuo YH
J Cell Biochem; 2020 Jan; 121(1):735-742. PubMed ID: 31478228
[TBL] [Abstract][Full Text] [Related]
6. EH-42: A Novel Small Molecule Induces Apoptosis and Inhibits Migration and Invasion of Human Hepatoma Cells through Suppressing STAT3 Signaling Pathway.
Gong QZ; Xiao D; Gong GY; Xu J; Wen XD; Feng F; Qu W
Curr Cancer Drug Targets; 2019; 19(7):583-593. PubMed ID: 30585547
[TBL] [Abstract][Full Text] [Related]
7. PKM2 promotes cell metastasis and inhibits autophagy via the JAK/STAT3 pathway in hepatocellular carcinoma.
Yu Z; Wang D; Tang Y
Mol Cell Biochem; 2021 May; 476(5):2001-2010. PubMed ID: 33512635
[TBL] [Abstract][Full Text] [Related]
8. SHC4 promotes tumor proliferation and metastasis by activating STAT3 signaling in hepatocellular carcinoma.
Zhang X; Zhang H; Liao Z; Zhang J; Liang H; Wang W; Yu J; Dong K
Cancer Cell Int; 2022 Jan; 22(1):24. PubMed ID: 35033067
[TBL] [Abstract][Full Text] [Related]
9. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
[TBL] [Abstract][Full Text] [Related]
10. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
[TBL] [Abstract][Full Text] [Related]
11. RPLP1 is highly expressed in hepatocellular carcinoma tissues and promotes proliferation, invasion and migration of human hepatocellular carcinoma Hep3b cells.
Xie C; Cao K; Peng D; Qin L
Exp Ther Med; 2021 Jul; 22(1):752. PubMed ID: 34035849
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of
He Z; Fan F; Xu Z; Zhang M; Zhao R; Ke X; Wang Q; Yan S; Zheng H
Transl Cancer Res; 2023 Jul; 12(7):1753-1764. PubMed ID: 37588735
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of amine oxidase copper containing 1 inhibits tumor progression by suppressing IL-6/JAK/STAT3 pathway activation in hepatocellular carcinoma.
Ding Q; Lin D; Zhou Y; Li F; Lai J; Duan J; Chen J; Jiang C
Oncol Lett; 2021 Dec; 22(6):857. PubMed ID: 34777591
[TBL] [Abstract][Full Text] [Related]
14. Rheum palmatum extract exerts anti-hepatocellular carcinoma effects by inhibiting signal transducer and activator of transcription 3 signaling.
Tan ZB; Fan HJ; Wu YT; Xie LP; Bi YM; Xu HL; Chen HM; Li J; Liu B; Zhou YC
J Ethnopharmacol; 2019 Mar; 232():62-72. PubMed ID: 30553869
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of CKS1B restrains the proliferation, migration, invasion and angiogenesis of retinoblastoma cells through the MEK/ERK signaling pathway.
Zeng Z; Gao ZL; Zhang ZP; Jiang HB; Yang CQ; Yang J; Xia XB
Int J Mol Med; 2019 Jul; 44(1):103-114. PubMed ID: 31115482
[TBL] [Abstract][Full Text] [Related]
16. MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma.
Huang B; Huang M; Li Q
Pathol Res Pract; 2018 Dec; 214(12):1980-1986. PubMed ID: 30274685
[TBL] [Abstract][Full Text] [Related]
17. Potential roles of EZH2, Bmi-1 and miR-203 in cell proliferation and invasion in hepatocellular carcinoma cell line Hep3B.
Yang F; Lv LZ; Cai QC; Jiang Y
World J Gastroenterol; 2015 Dec; 21(47):13268-76. PubMed ID: 26715809
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of RSPH14 inhibits proliferation, migration, and invasion and promotes apoptosis of hepatocellular carcinoma via RelA.
Yuan D; Ma R; Sun T; Zhu K; Dang C; Ye H; Li K
Cancer Cell Int; 2022 Mar; 22(1):129. PubMed ID: 35305640
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of LINC00657 inhibits the viability, migration and invasion of pancreatic cancer cells by regulating the miR-520h/CKS1B axis.
Li P; Wang H; Tang Y; Sun S; Ma Y; Xu Y; Chen G
Exp Ther Med; 2021 Oct; 22(4):1142. PubMed ID: 34504588
[TBL] [Abstract][Full Text] [Related]
20. NKAP plays an oncogenic function partly through AKT signaling pathway in hepatocellular carcinoma.
Song T; Liu JY; Yang JJ
Neoplasma; 2019 Sep; 66(5):792-800. PubMed ID: 31305121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
